A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction.

Abstract:

BACKGROUND:We evaluate a simple, bedside test that measures 1-minute heart rate variability in deep breathing as a predictor of death after myocardial infarction. METHODS:Bedside heart rate variability was assessed in 185 consecutive patients 5.1 +/- 2.5 days after a first myocardial infarction. Patients were instructed to take 6 deep respirations in 1 minute while changes in heart rate were measured and calculated by an electrocardiographic recorder. An abnormal test result was defined as a difference of less than 10 beats/min between the shortest and longest heart rate interval. RESULTS:Heart rate variability <10 beats/min was found in 65 patients (35%) and was significantly lower (P <.05) in women, patients >60 years of age, patients with diabetes, patients with congestive heart failure, and patients taking angiotensin-converting enzyme inhibitors. Mean follow-up period was 16 months. Ten patients died during follow-up: 9 of cardiac causes and 1 of stroke. Nine of these 10 patients had heart rate variability <10 beats/min (P =.004). The sensitivity and specificity of this test for cardiovascular mortality is 90.0% and 68.0%, respectively. The negative predictive value is 99.2% and the relative risk is 16.6. Heart rate variability <10 beats/min remained a significant predictor of death after adjusting for clinical, demographic, and left ventricular function with an odds ratio of 1.38 (95% confidence interval, 1.13-1.63). CONCLUSIONS:This simple, brief bedside deep breathing test of heart rate variability in patients after myocardial infarction appears to be a good predictor for all-cause mortality and sudden death. It may be used as a clinical test for risk stratification after myocardial infarction.

journal_name

Am Heart J

journal_title

American heart journal

authors

Katz A,Liberty IF,Porath A,Ovsyshcher I,Prystowsky EN

doi

10.1016/s0002-8703(99)70242-5

subject

Has Abstract

pub_date

1999-07-01 00:00:00

pages

32-8

issue

1 Pt 1

eissn

0002-8703

issn

1097-6744

pii

S0002-8703(99)70242-5

journal_volume

138

pub_type

杂志文章
  • Use of the invasive management strategy for patients with non-Q-wave myocardial infarction: an observational database report from the Worcester Heart Attack Study.

    abstract:BACKGROUND:Recent randomized clinical trials have suggested a benefit of an invasive management strategy in patients with acute coronary syndromes. However, the broader use and impact of the invasive management approach has not been established for patients with acute coronary syndromes beyond the relatively narrow pat...

    journal_title:American heart journal

    pub_type: 杂志文章,多中心研究

    doi:10.1067/mhj.2002.122517

    authors: Dauerman HL,Yarzebski J,Gore JM,Lessard D,Goldberg RJ

    更新日期:2002-06-01 00:00:00

  • Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting.

    abstract:BACKGROUND:The outpatient prognostic assessment of coronary artery disease (CAD) by exercise electrocardiography has limitations, including the feasibility of the test and its low positive predictive value in several clinical conditions. In the current study we investigated the safety, feasibility, and prognostic value...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1067/mhj.2001.113997

    authors: Cortigiani L,Picano E,Coletta C,Chiarella F,Mathias W,Gandolfo N,De Alcantara M,Mazzoni V,Gensini GF,Landi P,Echo Persantine International Cooperative (EPIC) Study Group.,Echo Dobutamine International Cooperative (EDIC) Study Group

    更新日期:2001-04-01 00:00:00

  • The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials.

    abstract::The novel oral anticoagulants (NOACs) have rapidly emerged as an alternative therapy to warfarin. Several recent phase 3 randomized control trials have demonstrated the efficacy and safety of the NOACs in the treatment for patients with nonvalvular atrial fibrillation. As the NOACs are incorporated in clinical practic...

    journal_title:American heart journal

    pub_type: 杂志文章,评审

    doi:10.1016/j.ahj.2014.12.008

    authors: Krishnamoorthy A,Sherwood MW,Lopes RD,Becker RC

    更新日期:2015-03-01 00:00:00

  • The alpha1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study.

    abstract:BACKGROUND:The recovery of left ventricular function (LVF) after revascularization takes time. alpha-Adrenergic blockade acutely improves coronary blood flow and LVF, whereas the effects of more prolonged alpha-adrenergic blockade on LVF recovery after stenting are unknown. METHODS:In 32 patients (age 58 +/- 12 y) wit...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.ahj.2003.08.005

    authors: Kozàkovà M,Marco J,Heusch G,Bernies M,Bossi IM,Palombo C,Anguissola GB,Donatelli F,Laurent JP,Gregorini L

    更新日期:2004-02-01 00:00:00

  • Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.

    abstract::In a double blind, placebo-controlled study, the efficacy of propafenone, a new antiarrhythmic drug was compared to that of disopyramide. Sixteen patients with frequent and complex premature ventricular contractions (PVCs) were studied by serial 24-hour ambulatory monitoring, while they were receiving propafenone, 300...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0002-8703(85)90647-7

    authors: Naccarella F,Bracchetti D,Palmieri M,Cantelli I,Bertaccini P,Ambrosioni E

    更新日期:1985-04-01 00:00:00

  • The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure.

    abstract::The effects of captopril (CPT), an oral angiotensin-converting enzyme (ACE) inhibitor, on systemic failure (CHF). In 15 patients, CPT decreased mean arterial pressure from 75 +/- 3 to 60 +/- 3 mm Hg associated with a 16% increase in cardiac output, a 24% reduction in systemic vascular resistance, and a 36% decrease in...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/0002-8703(82)90052-7

    authors: Powers ER,Bannerman KS,Stone J,Reison DS,Escala EL,Kalischer A,Weiss MB,Sciacca RR,Cannon PJ

    更新日期:1982-11-01 00:00:00

  • Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial.

    abstract:BACKGROUND:Patients with left ventricular dysfunction who undergo coronary artery bypass graft (CABG) surgery frequently have late sudden cardiac death. The CABG Patch Trial is a prospective, randomized, multicenter clinical trial that randomized patients at high risk at the completion of CABG surgery to implantation o...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0002-8703(97)80001-4

    authors: Curtis AB,Cannom DS,Bigger JT Jr,DiMarco JP,Estes NA 3rd,Steinman RC,Parides MK

    更新日期:1997-11-01 00:00:00

  • Effect of exercise training on ventricular function, dyssynchrony, resting myocardial perfusion, and clinical outcomes in patients with heart failure: a nuclear ancillary study of Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Tra

    abstract:BACKGROUND:Technetium Tc 99m gated single photon emission computed tomography (SPECT) has become the cornerstone of noninvasive risk stratification in patients with ischemic heart disease, but its role in patients with heart failure is not as well established. STUDY DESIGN:This study is a substudy of the Heart Failure...

    journal_title:American heart journal

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.ahj.2007.03.045

    authors: Bensimhon DR,Adams GL,Whellan DJ,Pagnanelli RA,Trimble M,Lee BA,Lee KL,Ellis SJ,Kraus WE,Rendall DS,Iskandrian AE,O'Connor CM,Borges-Neto S,HF-ACTION Trial Investigators.

    更新日期:2007-07-01 00:00:00

  • Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.

    abstract::Patients with impaired glucose tolerance (IGT) have increased risk for developing type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Lifestyle modification and medication can prevent or delay progression to diabetes (PD), but whether such interventions also reduce the risk of CVD has not been rigorously...

    journal_title:American heart journal

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.ahj.2008.05.017

    authors: Califf RM,Boolell M,Haffner SM,Bethel M,McMurray J,Duggal A,Holman RR,NAVIGATOR Study Group.

    更新日期:2008-10-01 00:00:00

  • Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.

    abstract:BACKGROUND:Endothelial progenitor cells (EPCs) are present in peripheral blood and can promote postnatal angiogenesis. The number and function of circulating EPCs are altered in diabetics. This study sought to investigate whether the number and functional properties of EPCs from patients with type II diabetes could be ...

    journal_title:American heart journal

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.ahj.2006.07.029

    authors: Wang CH,Ting MK,Verma S,Kuo LT,Yang NI,Hsieh IC,Wang SY,Hung A,Cherng WJ

    更新日期:2006-12-01 00:00:00

  • Identification of patients at high risk for death and cardiac ischemic events after hospital discharge.

    abstract:BACKGROUND:Patients with unstable angina (UA) and non-ST-elevation myocardial infarction (NSTEMI) remain at risk for death and cardiac ischemic events after being discharged from the hospital. METHODS:We examined whether the Thrombolysis In Myocardial Infarction (TIMI) risk score for UA/NSTEMI, ascertained at presenta...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1067/mhj.2002.122870

    authors: Sabatine MS,McCabe CH,Morrow DA,Giugliano RP,de Lemos JA,Cohen M,Antman EM,Braunwald E

    更新日期:2002-06-01 00:00:00

  • The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study.

    abstract:BACKGROUND:Enhanced external counterpulsation (EECP) reduces angina and extends time to exercise-induced ischemia in patients with symptomatic coronary disease. One- and two-center studies and a retrospective case series reported that EECP improves myocardial perfusion in stable angina pectoris. We sought to critically...

    journal_title:American heart journal

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.ahj.2005.01.054

    authors: Michaels AD,Raisinghani A,Soran O,de Lame PA,Lemaire ML,Kligfield P,Watson DD,Conti CR,Beller G

    更新日期:2005-11-01 00:00:00

  • Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

    abstract:BACKGROUND:Several non-vitamin K antagonist oral anticoagulant (NOAC) alternatives to warfarin are available for stroke prevention in atrial fibrillation (AF). We aimed to describe the factors associated with selection of NOACs versus warfarin in patients with new onset AF. METHODS:The ORBIT-AF II study is a national,...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.ahj.2017.03.024

    authors: Steinberg BA,Shrader P,Thomas L,Ansell J,Fonarow GC,Gersh BJ,Hylek E,Kowey PR,Mahaffey KW,O'Brien EC,Singer DE,Peterson ED,Piccini JP,Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigato

    更新日期:2017-07-01 00:00:00

  • Atherosclerosis: an update.

    abstract::CHD remains the leading cause of death in most developed countries; therefore, elucidation of risk factors and associated mechanisms for atherosclerosis and development of CHD has been a high priority. Data from the Framingham Heart Study and other large-scale epidemiologic studies have identified major risk factors a...

    journal_title:American heart journal

    pub_type: 杂志文章,评审

    doi:10.1016/s0002-8703(96)90096-4

    authors: Basha BJ,Sowers JR

    更新日期:1996-06-01 00:00:00

  • Spatial, individual, and temporal variation of the high-frequency QRS amplitudes in the 12 standard electrocardiographic leads.

    abstract:BACKGROUND:Analysis of high-frequency QRS amplitudes (HF-QRS) may provide an additional diagnostic tool in patients with heart disease, but the basic properties of these waveforms have not been sufficiently investigated. This study describes the spatial, individual, and temporal variation at rest of HF-QRS recorded wit...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1067/mhj.2000.101782

    authors: Pettersson J,Carro E,Edenbrandt L,Maynard C,Pahlm O,Ringborn M,Sörnmo L,Warren SG,Wagner GS

    更新日期:2000-02-01 00:00:00

  • Mode of deployment of coronary Palmaz-Schatz stents after implantation with the stent delivery system: an intravascular ultrasound study.

    abstract::The stent delivery system (SDS) is a sheath-covered Palmaz-Schatz stent mounted on a 3.0, 3.5, or 4.0 mm compliant polyethylene balloon catheter; the balloon resists maximal inflation pressures of 5.7, 6.2, or 6.0 atm, respectively. It is postulated that these pressures are too low to obtain optimal stent deployment. ...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/0002-8703(95)90308-9

    authors: Kiemeneij F,Laarman G,Slagboom T

    更新日期:1995-04-01 00:00:00

  • The triglyceride-high-density lipoprotein axis: an important target of therapy?

    abstract::Coronary heart disease is the single largest cause of morbidity and mortality in the United States. The link between elevated low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) has been clearly established. However, triglycerides (TG) are increasingly believed to be independently assoc...

    journal_title:American heart journal

    pub_type: 杂志文章,评审

    doi:10.1016/j.ahj.2004.03.037

    authors: Szapary PO,Rader DJ

    更新日期:2004-08-01 00:00:00

  • No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy.

    abstract:BACKGROUND:Dilated and hypertrophic cardiomyopathies are primary myocardial diseases that cause considerable morbidity and mortality. Although these cardiomyopathies are clinically heterogeneous, genetic factors play an important role in their etiology and pathogenesis. The defects in the cardiac actin (ACTC) gene can ...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1067/mhj.2002.122514

    authors: Kärkkäinen S,Peuhkurinen K,Jääskeläinen P,Miettinen R,Kärkkäinen P,Kuusisto J,Laakso M

    更新日期:2002-06-01 00:00:00

  • Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective.

    abstract:BACKGROUND:Limited information is available about recent trends in the incidence and death rates from atrial fibrillation (AF) complicating acute myocardial infarction (AMI). The purpose of this study was to examine the impact and trends over time of AF complicating initial AMI. METHODS:We conducted a longitudinal stu...

    journal_title:American heart journal

    pub_type: 杂志文章,多中心研究

    doi:10.1067/mhj.2002.120410

    authors: Goldberg RJ,Yarzebski J,Lessard D,Wu J,Gore JM

    更新日期:2002-03-01 00:00:00

  • Validation of an automated electronic algorithm and "dashboard" to identify and characterize decompensated heart failure admissions across a medical center.

    abstract:BACKGROUND:We aim to validate the diagnostic performance of the first fully automatic, electronic heart failure (HF) identification algorithm and evaluate the implementation of an HF Dashboard system with 2 components: real-time identification of decompensated HF admissions and accurate characterization of disease char...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2016.10.001

    authors: Cox ZL,Lewis CM,Lai P,Lenihan DJ

    更新日期:2017-01-01 00:00:00

  • The sick-sinus syndrome in Africans.

    abstract::Fifteen cases of the sick-sinus syndrome in young Negroes are presented. The etiology was unknown in all cases; organic heart disease was absent. The very high default rate suggests that the prognosis may be grave. This disorder is by no means uncommon in young persons in tropical countries and the dangers of a mistak...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/0002-8703(75)90078-2

    authors: Ikeme AC,D'Arbela PG,Somers K

    更新日期:1975-03-01 00:00:00

  • Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries.

    abstract:BACKGROUND:Diabetic nephropathy is associated with increased cardiovascular events. Coronary atherosclerosis is responsible for many of these events, but other mechanisms such as impaired flow reserve may be involved. The purpose of this study was to define the prevalence and mechanism of abnormal coronary velocity res...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2003.07.029

    authors: Ragosta M,Samady H,Isaacs RB,Gimple LW,Sarembock IJ,Powers ER

    更新日期:2004-06-01 00:00:00

  • Rupture of interventricular septum in acute myocardial infarction.

    abstract::Three cases of rupture of the interventricular septum occurring coincident with acute inferior myocardial infarction are reported and the relevant literature is reviewed. One patient under-went successful surgical repair and, in addition, had an aneurysmectomy. Clues and pitfalls in diagnosis as well as the possible c...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/s0002-8703(76)80407-3

    authors: Longo EA,Cohen LS

    更新日期:1976-07-01 00:00:00

  • Cardiac and vascular effects of fingolimod: mechanistic basis and clinical implications.

    abstract::Fingolimod, a sphingosine-1-phosphate receptor (S1PR) modulator, was the first oral disease-modifying therapy approved for relapsing forms of multiple sclerosis; it reduces autoreactive lymphocytes' egress from lymphoid tissues by down-regulating S1PRs. Sphingosine-1-phosphate signaling is implicated in a range of phy...

    journal_title:American heart journal

    pub_type: 杂志文章,评审

    doi:10.1016/j.ahj.2014.06.028

    authors: Camm J,Hla T,Bakshi R,Brinkmann V

    更新日期:2014-11-01 00:00:00

  • Complex atrial arrhythmias studied by suction electrode technique.

    abstract::Two elderly patients with coronary heart disease, chronic pulmonary disease, and complex atrial arrhythmias are presented. The suction electrode technique for right atrium monophasic action potential recording was used. This recording allows better analysis of the atrial arrhythmias and estimates the stability of foca...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/0002-8703(75)90126-x

    authors: Cotoi S,Dragulescu SI

    更新日期:1975-08-01 00:00:00

  • Exercise-induced alterations of signal-averaged electrocardiograms in marathon runners.

    abstract::Late potentials have been shown to predict malignant ventricular arrhythmias and sudden cardiac death. To determine whether prolonged, strenuous activity is associated with the development of ventricular late potentials, signal-averaged electrocardiography was performed on 30 marathon runners before, immediately after...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/0002-8703(89)90010-0

    authors: Smith GS,Vacek JL,Wilson DB,Hawkins JW,Boyer TA

    更新日期:1989-12-01 00:00:00

  • Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.

    abstract:AIMS:Furosemide is commonly prescribed for symptom relief in heart failure (HF) patients. Although few data support the continuous use of loop diuretics in apparently euvolemic HF patients with mild symptoms, there is concern about safety of diuretic withdrawal in these patients. The ReBIC-1 trial was designed to evalu...

    journal_title:American heart journal

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.ahj.2017.08.012

    authors: da Rosa PR,Rohde LE,Doebber M,Ribeiro ALP,Prado DP,Bertoldi EG,Figueiredo Neto JA,Kohler I,Beck-da-Silva L,Danzmann LC,Moura LZ,Rover M,Simões MV,Sant'Anna RT,Biolo A

    更新日期:2017-12-01 00:00:00

  • Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.

    abstract:BACKGROUND:Circulating mediators, including thromboxane A2, the vasoconstrictor, platelet aggregant, and smooth muscle mitogen, may contribute to the progression of vascular narrowing in primary pulmonary hypertension (PPH). METHODS:To further understand the contribution of thromboxane and to provide novel therapy for...

    journal_title:American heart journal

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1067/mhj.2002.121806

    authors: Langleben D,Christman BW,Barst RJ,Dias VC,Galiè N,Higenbottam TW,Kneussl M,Korducki L,Naeije R,Riedel A,Simonneau G,Hirsch AM,Rich S,Robbins IM,Oudiz R,McGoon MD,Badesch DB,Levy RD,Mehta S,Seeger W,Solèr M

    更新日期:2002-05-01 00:00:00

  • The association between body mass index and coronary artery disease severity: a comparison of black and white patients.

    abstract:INTRODUCTION:Despite known associations between obesity and cardiovascular disease, the relationship between obesity as reflected by body mass index (BMI) and angiographic coronary artery disease (CAD) is not fully understood. Moreover, this relationship has not been adequately defined in black patients, a group demons...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2013.12.009

    authors: Stalls CM,Triplette MA,Viera AJ,Pathman DE,Cohen MG,Rossi JS

    更新日期:2014-04-01 00:00:00

  • Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study.

    abstract:BACKGROUND:According to a recent meta-analysis, parathyroid hormone (PTH) excess is associated with increased cardiovascular disease (CVD) risk, but existing studies are limited. We examined in a prospective study the association of PTH with the incidence of CVD, taking into account vitamin D and other confounding vari...

    journal_title:American heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ahj.2014.04.017

    authors: Folsom AR,Alonso A,Misialek JR,Michos ED,Selvin E,Eckfeldt JH,Coresh J,Pankow JS,Lutsey PL

    更新日期:2014-09-01 00:00:00